Bing

SEARCH HISTORY

Slightly less than a year after GlaxoSmithKline ($GSK) and Amicus Therapeutics reported ... buying Callidus Biopharma for $15 million in stock and a promise of $115 million in development milestones, acquiring an enzyme replacement therapy for Pompe ...
Fierce Biotech · ByJohn Carroll · 11/21/2013
In addition, we have an economic interest in future payments that may be made by GSK pursuant to its agreements with Theravance, Inc. relating to certain drug development programs, including the combination of fluticasone furoate, umeclidinium, and ...
Stockhouse · 1 day ago
In September 2014, UK-based pharmaceuticals giant GlaxoSmithKline (GSK ... the case had already caused significant damage to the company’s reputation and stock. Plans of a $2.2bn buyout by aerospace firm Lockheed Martin had fallen through in …
worldfinance.com · 3/6/2015
More from Bing News
GlaxoSmithKline (GSK) Consumer Healthcare has named Zubair Ahmed as head of Asia Pacific ... one of the two public listed arms of GSK in India, as per a stock market disclosure. In April this year, GSK and Novartis agreed to form a global consumer ...
VC Circle · 10/8/2014
GSK sells HIV medicines through its majority-owned ViiV Healthcare unit, which it had been considering for a stock market listing, until a change of tack on May 6. Its investment at Chapel Hill is separate from ViiV, although ViiV will play an advisory role.
Thomson Reuters Foundation · 5/11/2015
My share portfolio is carefully researched, each stock a leader in a sector ... The past seven days focussed on news out of Netcare, Brait, SpaceX, Pioneer Foods, GSK, Redefine and PSG. The common thread: central …
biznews.com · 5/21/2015
International’s nine managers, employees of Milwaukee-based Fiduciary Management, run two other standout funds: FMI Common Stock (FMIMX), which focuses ... acquired it, and GlaxoSmithKline (GSK) after deciding that the British drugmaker …
Kiplinger · 2/2/2015
Have been losing some HIV share to GlaxoSmithKline (GSK). 5 ... Given this outlook, we see our target price of $125 as being highly achievable, even if the stock retains its current discounted multiple amongst its peers.
Barron's · 4/30/2015
The drug maker GlaxoSmithKline reported Wednesday that its third-quarter ... In trading on the New York Stock Exchange, Glaxo shares dropped 99 cents, or 1.9 percent, to close at $50.76. For the first nine months, the company said its worldwide sales ...
New York Times · ByBarry Meier · 10/24/2013
where it has a stock market listing. REPUTATIONAL DAMAGE The Aug. 6 email from a person familiar with GSK's Syrian operations said the alleged bribes in its pharmaceuticals business took the form of cash, trips and free medical samples. "GSK has …
Finance Yahoo · ByBen Hirschler · 8/11/2014
Related Searches